Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
Penn Medicine Commercialization Speaker Series – Fall 2022
This fall, the Penn Center for Innovation and Penn Medicine present three monthly speaker sessions with experts in the field of Life Sciences investing, university startups, and intellectual property.
PCI Startup ŌNŌCOR Reports First-In-Human Use of the ŌNŌ Retrieval System
Tumors within the heart affect thousands of patients around the world annually, but prior to the ŌNŌ system, open-heart surgery was the only way to remove them.
President’s Innovation Prize Winner Lumify Care and PCI Startup Neuralert Hit Major Milestones in 2022
Lumify Care and Neuralert have grown rapidly in terms of funding and product expansion.
Penn Graduate Receives President’s Sustainability Prize for Robotics-Based System to Minimize Waste in Fishing Industry
Shinkei Systems cuts down on waste by reducing the likelihood that off-target species would be caught and killed, and streamlining the process to avoid waste.
Former Fellow Dr. Rosa María Álvarez, PhD Guest Speaks for PCI Fellows Program
Rosa's experience working in the lab and participating in the PCI Fellows program at Penn helped her gain valuable experience for her career at Deloitte.
Marion Leary Speaks on her Innovation-Focused Nursing Career
Learn about Marion Leary and her mission to help health professionals pursue a career path in innovation.
PCI Fellows Program trains future commercialization leaders
PCI Fellows get exposure to a wide range of emerging technologies and commercialization opportunities in the life sciences, physical sciences, nanotechnology, and beyond.
Penn researchers invent microrobots to brush teeth
In a proof-of-concept study, a robotic microswarm of nanoparticles, arranged in bristle-like structures, effectively cleaned plaque and decay-causing bacteria from both mock and human teeth.
Press Highlights of FY22
During the 2022 fiscal year, there were 98 press mentions for PCI programs, startups and partners. Some of the most popular and widely circulated stories are included here.
Peroxitech raises $25M Series A
PCIV startup Peroxitech Inc. announced the successful completion of a $25M Series A financing for treatment of acute lung injury (ALI) into clinical development.